E Fund Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$201K Sell
2025
Q1
$296K Buy
2024
Q4
$286K Sell
2024
Q3
$286K Buy
2024
Q2
$181K Sell
2024
Q1
$386K Sell
2023
Q4
$533K Sell
2023
Q3
$434K Buy
2023
Q2
$129K Sell
2023
Q1
$143K Sell
2022
Q4
$209K Buy
2022
Q3
$126K Buy